solubilityH2O: 50 mg/mL formWhite solid pka4(at 25℃) colorWhite to Almost white Water SolubilitySoluble in water to 50mg/ml. Merck14,3081 BCS Class2 StabilityStable. InChIInChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,...
DOSE/DURATION : 280 mg/kg/28D-I TOXIC EFFECTS : Gastrointestinal - alteration in gastric secretion Kidney, Ureter, Bladder - other changes Related to Chronic Data - death REFERENCE : AITEAT Archivum Immunologiae et Therapiae Experimentalis. (Ars Polona, POB 1001, 00-068 Warsaw 1, Pol...
The gastroduodenal tolerance of Tenoxicam and Diclofenac Na has been evaluated in a double-blind, parallel group study in 36 healthy male volunteers. The d... P Müller,HG Dammann,U Leucht,... - 《European Journal of Clinical Pharmacology》 被引量: 58发表: 1989年 ...
Synonyms: N-(2,6-Dichlorophenyl)-o-aminophenylacetic acid sodium salt;OOTHECA MANTIDIS;Diclofenac SodiuM EC pellets 32%;Diclofenac SodiuM SR pellets 32%;Diclofenac Sodium (200 mg);DelphiMix;Diacron;Naclof CAS NO:15307-79-6 Molecular Formula: C14H10Cl2NO2*Na Molecular Weight: 318.13 EINECS: 23...
(mgDCF/gMIPs)R2-KF(mg/g)*(L/mg)1/na.u.R2- MIPs 0.0119 37.7 0.9994 2.55 0.371 0.9868 NIPs 0.0142 19.0 0.9961 1.79 0.424 0.9038 The imprinting factor (IF) characterizes MIP binding capacity over that for non-imprinted polymer, and it is the simplest estimation of the imprinting effect. ...
M01AB05 DOLPHIN NA solution for injection 75 mg/3 ml Solution for injection M01AB05 DOLPASSE suppository 100 mg Suppository M01AB05 OPTAMAX coated tablet 50 mg Coated tablet M01AB05 CAMBIA powder for oral solution 50 mg Powder for oral solution M01AB05 DEALGIC prolonged-release capsule, ...
Diclofenac 75 to 150mg daily administered orally, rectally or intramuscularly is an effective analgesic and anti-inflammatory agent in the treatment of various rheumatic conditions (e.g. tendinitis, bursitis, sciatica, myalgia) and acute soft tissue injuries (e.g. strains, sprains). It is also ...
Products containing the association of diclofenac/cyclodextrins are available for subcutaneous, intramuscular, and intravenous administration in doses that range from 25 to 75 mg. Medicinal products containing the association of progesterone/cyclodextrins are indicated for intramuscular and subcutaneous injection...
(1.5 mg l−1). Co-metabolic biodegradation microcosms were also set up, next to the pharmaceutical compound easily assimilable carbon sources such as yeast extract (0.05 or 0.3 g l−1) or glucose (0.5 or 3 g l−1) were added. Biodegradation experiments were also carried out in R2A...
[125]. Pharmacokinetic properties of diclofenac sodium in the fixed-dose combination with misoprostol were generally similar to those of enteric-coated diclofenac sodium when administered as monotherapy [125]. On average, meanCmaxwas approximately 1.5 or 2.0 µg/mL for 50 or 75-mg doses, ...